These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 8223850

  • 1. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H, Kuzu Y, Kuzu H, Brumeanu TD, Swiggard WJ, Steinman RM, Bona CA.
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [Abstract] [Full Text] [Related]

  • 2. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ, Rhodes J, Liew FY, Tite JP.
    J Immunol; 1993 Apr 01; 150(7):2869-84. PubMed ID: 7681081
    [Abstract] [Full Text] [Related]

  • 3. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM, Turner RV, Biddison WE, Coligan JE.
    J Immunol; 1992 Feb 01; 148(3):894-9. PubMed ID: 1370522
    [Abstract] [Full Text] [Related]

  • 4. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies.
    Anton LC, Yewdell JW, Bennink JR.
    J Immunol; 1997 Mar 15; 158(6):2535-42. PubMed ID: 9058784
    [Abstract] [Full Text] [Related]

  • 5. Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide.
    Billetta R, Filaci G, Zanetti M.
    Eur J Immunol; 1995 Mar 15; 25(3):776-83. PubMed ID: 7705408
    [Abstract] [Full Text] [Related]

  • 6. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E, Horváth A, Gogolák P, Tóth GK, Fazekas G, Fridkin M, Pecht I.
    Eur J Immunol; 1997 Dec 15; 27(12):3105-14. PubMed ID: 9464794
    [Abstract] [Full Text] [Related]

  • 7. Fine specificity of murine class II-restricted T cell clones for synthetic peptides of influenza virus hemagglutinin. Heterogeneity of antigen interaction with the T cell and the Ia molecule.
    Mills KH, Burt DS, Skehel JJ, Thomas DB.
    J Immunol; 1988 Jun 15; 140(12):4083-90. PubMed ID: 2453566
    [Abstract] [Full Text] [Related]

  • 8. The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen.
    Milligan GN, Morrison LA, Gorka J, Braciale VL, Braciale TJ.
    J Immunol; 1990 Nov 15; 145(10):3188-93. PubMed ID: 1700000
    [Abstract] [Full Text] [Related]

  • 9. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M, Eisenlohr LC, Otvos L, Horowitz D, Yewdell JW, Bennink JR, Hackett CJ.
    Virology; 1994 May 15; 201(1):86-94. PubMed ID: 7513927
    [Abstract] [Full Text] [Related]

  • 10. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
    Pinet V, Malnati MS, Long EO.
    J Immunol; 1994 May 15; 152(10):4852-60. PubMed ID: 8176208
    [Abstract] [Full Text] [Related]

  • 11. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells.
    Malnati MS, Marti M, LaVaute T, Jaraquemada D, Biddison W, DeMars R, Long EO.
    Nature; 1992 Jun 25; 357(6380):702-4. PubMed ID: 1614517
    [Abstract] [Full Text] [Related]

  • 12. Viral hemagglutinin augments peptide-specific cytotoxic T cell responses.
    Ertel C, Millar NS, Emmerson PT, Schirrmacher V, von Hoegen P.
    Eur J Immunol; 1993 Oct 25; 23(10):2592-6. PubMed ID: 8405059
    [Abstract] [Full Text] [Related]

  • 13. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB, Smith CA, Graham CM.
    J Immunol; 1996 Sep 15; 157(6):2386-94. PubMed ID: 8805637
    [Abstract] [Full Text] [Related]

  • 14. Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation.
    Hackett CJ, Yewdell JW, Bennink JR, Wysocka M.
    J Immunol; 1991 May 01; 146(9):2944-51. PubMed ID: 1673146
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. I-Ad restricted T cell recognition of influenza hemagglutinin. Synthetic peptides identify multiple epitopes corresponding to antibody-binding regions of the HA1 subunit.
    Barnett BC, Burt DS, Graham CM, Warren AP, Skehel JJ, Thomas DB.
    J Immunol; 1989 Oct 15; 143(8):2663-9. PubMed ID: 2477451
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L, Ullrich SJ, Appella E, Fuchs S.
    Nature; 1990 Jul 05; 346(6279):63-6. PubMed ID: 2366863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.